DHR
Danaher·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 5
Bearish signal 2
Consensus Rating "Buy"
MACD Death Cross
Ample Liquidity
High Gross Profit Margin
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About DHR
Danaher Corporation
A global science and technology innovator that has leadership positions in the demanding and attractive health care, environmental and applied end-markets
Life Science Tools and Services
--
12/10/1969
New York Stock Exchange
63,000
12-31
Common stock
2200 Pennsylvania Ave. N.W., Suite 800W, Washington, D.C. 20037-1701
Manufacture and sale of life science and diagnostic facilities
Danaher Corporation, originally named DMG, was formed in 1969 as a Massachusetts Caretrust Reit. The company designs, manufactures and sells professional, medical, industrial and commercial products and services that are typically characterized by strong brand names, innovative technologies and dominant market positions. The company's business consists of five parts: test and measurement, environment, life science and diagnosis, dentistry and industrial technology. The company's research and development, manufacturing, sales, distribution, service and management facilities are located in more than 50 countries.
Earnings Call
Q1/2025
Estimate EPS1.64
Actual EPS1.88
Estimate Revenue5.59B
Actual Revenue5.74B
Danaher's Q1 2025 Earnings Call: Unpacking Contradictions in Diagnostics, Life Sciences, and China Market Dynamics
Apr 23,2025 08:59
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
DHR has released its 2025 Q3 earnings. EPS was reported at 1.89, versus the expected 1.72, beating expectations. The chart below visualizes how DHR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
DHR has released its 2025 Q3 earnings report, with revenue of 6.05B, reflecting a YoY change of 4.40%, and net profit of 908.00M, showing a YoY change of 11.00%. The Sankey diagram below clearly presents DHR's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
